Therefore, we speculate that synergistic effects might be induced by a combination of SGLT2i and insulin therapy, which could explain the beneficial effects of combination of these two agents in individuals with long-standing T2D [45]. This evidence concerns the gene INS and type 2 diabetes mellitus.